CD28 and colonic neoplasm: Kamphorst et al. (102), using mice treated with B7 antibody and PD-L1 inhibitor, demonstrated that inhibition of CD28 leads to the progression of colon cancer and inhibition of T-cell expansion in CD28 knockout mice using PD-L1 inhibitor alone.